Akums Drugs & Pharmaceuticals Ltd.
Fundamentals
- Market cap
- ₹8,185 cr
- P/E
- 73.32×
- ROE
- 11.10%
- Debt / equity
- 0.00
- Div yield
- 0.58%
- 52-week range
- 409.30 — 622.95
The timeline — 2 notes on Akums Drugs & Pharmaceuticals Ltd.
May 2026
- 21 May 26 · 12:41 IST Brief Brief · Earnings
Akums FY26 call transcript adds nothing new after earlier disclosure
The full transcript of the Q4 FY26 call confirms results already known. No material surprise for the market.
- 20 May 26 · 19:09 IST Brief Brief · Order Wins
Akums gets ₹133.75 cr tax notice, says it will appeal
IT assessment demands 52% of FY26 profit, but management calls it unsustainable and plans to challenge.